570 related articles for article (PubMed ID: 11807956)
1. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
McVean M; Weinberg WC; Pelling JC
Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
[TBL] [Abstract][Full Text] [Related]
2. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
3. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF
Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
5. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes.
Lepley DM; Li B; Birt DF; Pelling JC
Carcinogenesis; 1996 Nov; 17(11):2367-75. PubMed ID: 8968050
[TBL] [Abstract][Full Text] [Related]
6. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
Choi YH; Lee WH; Park KY; Zhang L
Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
[TBL] [Abstract][Full Text] [Related]
7. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
Poon RY; Chau MS; Yamashita K; Hunter T
Cancer Res; 1997 Nov; 57(22):5168-78. PubMed ID: 9371520
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53.
Athar M; Kim AL; Ahmad N; Mukhtar H; Gautier J; Bickers DR
Biochem Biophys Res Commun; 2000 Oct; 277(1):107-11. PubMed ID: 11027648
[TBL] [Abstract][Full Text] [Related]
9. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1.
Chang KL; Kung ML; Chow NH; Su SJ
Biochem Pharmacol; 2004 Feb; 67(4):717-26. PubMed ID: 14757171
[TBL] [Abstract][Full Text] [Related]
10. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
11. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
Kim MJ; Lee JY; Lee SJ
Oncol Rep; 2008 May; 19(5):1323-9. PubMed ID: 18425394
[TBL] [Abstract][Full Text] [Related]
12. p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity.
Normand G; Hemmati PG; Verdoodt B; von Haefen C; Wendt J; Güner D; May E; Dörken B; Daniel PT
J Biol Chem; 2005 Feb; 280(8):7118-30. PubMed ID: 15582998
[TBL] [Abstract][Full Text] [Related]
13. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells.
Hsu SL; Chen MC; Chou YH; Hwang GY; Yin SC
Exp Cell Res; 1999 Apr; 248(1):87-96. PubMed ID: 10094816
[TBL] [Abstract][Full Text] [Related]
14. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
[TBL] [Abstract][Full Text] [Related]
15. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest.
Ujiki MB; Ding XZ; Salabat MR; Bentrem DJ; Golkar L; Milam B; Talamonti MS; Bell RH; Iwamura T; Adrian TE
Mol Cancer; 2006 Dec; 5():76. PubMed ID: 17196098
[TBL] [Abstract][Full Text] [Related]
16. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
17. Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest.
Zhang Z; Leonard SS; Huang C; Vallyathan V; Castranova V; Shi X
Free Radic Biol Med; 2003 May; 34(10):1333-42. PubMed ID: 12726921
[TBL] [Abstract][Full Text] [Related]
18. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells.
Choi YH; Zhang L; Lee WH; Park KY
Int J Oncol; 1998 Aug; 13(2):391-6. PubMed ID: 9664138
[TBL] [Abstract][Full Text] [Related]
19. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo.
Nguyen TH; Ong CK; Wong E; Leong CT; Panasci L; Huynh H
Int J Oncol; 2005 Oct; 27(4):1131-40. PubMed ID: 16142332
[TBL] [Abstract][Full Text] [Related]
20. Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex.
Zhang XH; Zou ZQ; Xu CW; Shen YZ; Li D
Mol Med Rep; 2011; 4(2):273-7. PubMed ID: 21468563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
